Related Experiment Video
Updated: Feb 8, 2026

Microfluidic Bioprinting for Engineering Vascularized Tissues and Organoids
Published on: August 11, 2017
3-D bioprinting technologies in tissue engineering and regenerative medicine: Current and future trends
Elliot S Bishop1,2, Sami Mostafa3, Mikhail Pakvasa3
1Laboratory of Craniofacial Biology and Development, Section of Plastic and Reconstructive Surgery, Department of Surgery, The University of Chicago Medicine, Chicago, IL 60637, USA.
Abstract:
Advances in three-dimensional (3D) printing have increased feasibility towards the synthesis of living tissues. Known as 3D bioprinting, this technology involves the precise layering of cells, biologic scaffolds, and growth factors with the goal of creating bioidentical tissue for a variety of uses. Early successes have demonstrated distinct advantages over conventional tissue engineering strategies. Not surprisingly, there are current challenges to address before 3D bioprinting becomes clinically relevant. Here we provide an overview of 3D bioprinting technology and discuss key advances, clinical applications, and current limitations. While 3D bioprinting is a relatively novel tissue engineering strategy, it holds great potential to play a key role in personalized medicine.
Related Concept Videos
Current Trends in Nursing I
Current Trends in Nursing II
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
What is Genetic Engineering?
Microorganisms in Medicine and Therapeutics
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

